Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular dynamics insights into combustion mechanisms of JP-10/aluminum nanoparticle composite fuels.

RSC advances·2026

Same author

Quantifying the stability of influenza virus during evaporation and suspension phases using a novel bioaerosol experimental system.

Journal of hazardous materials·2026

Same author

Heat and low-density lipoprotein transfer in healthy aorta using fluid-structure interaction method.

Biomechanics and modeling in mechanobiology·2025

Same author

A multi-constituent model of thrombosis for blood-contacting medical devices.

Computer methods and programs in biomedicine·2025

Same author

Circulating Proteomic Panels for Noninvasive Diagnosis and Prognostication of Thromboangiitis Obliterans.

Journal of proteome research·2025

Same author

Influence of Geometric Parameters on the Hemodynamic Characteristics of the Vertebral Artery.

Journal of biomechanical engineering·2025

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Model reduction of coagulation cascade based on genetic algorithm.

Yan Wang¹, Jingyang Luan², Kun Luo¹

¹State Key Laboratory of Clean Energy Utilization, Zhejiang University, Hangzhou, China.

International Journal for Numerical Methods in Biomedical Engineering

|September 28, 2022

Summary

This summary is machine-generated.

Researchers developed a new framework to simplify complex blood coagulation models. This reduced-order model accurately captures fibrin generation kinetics, aiding thrombosis research.

Keywords:

coagulation cascade fibrin fibrinogenesis genetic algorithm reduced-order modeling

More Related Videos

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

Related Experiment Videos

Last Updated: Aug 27, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

High-Throughput Metabolic Profiling for Model Refinements of Microalgae

Published on: December 4, 2021

Area of Science:

Biophysics
Computational Biology
Biomedical Engineering

Background:

Fibrin is crucial for platelet stabilization in the coagulation cascade.
Full coagulation cascade models are computationally expensive for thrombosis simulations.
Simplified models can capture essential coagulation dynamics.

Purpose of the Study:

To develop a systematic approach for creating a reduced-order model of fibrin generation.
To reduce computational costs in thrombosis modeling while retaining key coagulation aspects.

Main Methods:

A semi-automatic framework was introduced for model-reduction of cascade reactions.
Protein species and reactions were selected based on literature and full model simulations.
A genetic algorithm optimized reaction rates for the reduced cascade network.

Main Results:

A 10-species reduced-order model was successfully developed from a 19-species model.
The reduced model accurately reproduced fibrinogenesis kinetics across varying tissue factor concentrations.
The framework demonstrated effective model-reduction for cascade reactions.

Conclusions:

The reduced-order model of fibrinogenesis is valuable for integrated thrombosis modeling.
This framework offers a method for simplifying other complex cascade reaction systems.
Computational efficiency in thrombosis research can be significantly improved.